Lindsell Train’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258M Sell
514,512
-102,699
-17% -$49.3M 9.81% 4
2026
Q1
$303M Sell
617,211
-72,292
-10% -$39.2M 9.67% 5
2025
Q4
$400M Sell
689,503
-128,026
-16% -$72.4M 10.13% 4
2025
Q3
$397M Sell
817,529
-37,083
-4% -$17.3M 9.73% 5
2025
Q2
$347M Buy
854,612
+345,822
+68% +$145M 8.17% 7
2025
Q1
$253M Buy
508,790
+101,550
+25% +$55M 7.01% 8
2024
Q4
$212M Buy
+407,240
New +$224M 5.3% 9

Other funds holding TMO

Lindsell Train's TMO Position: Q2 2026 in Review

Lindsell Train reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $49.3M and leaving 514,512 shares worth $258M. The position accounts for 9.81% of the portfolio, ranked #4.

Lindsell Train first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $400M in Q4 2025. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Lindsell Train held 514,512 shares of Thermo Fisher Scientific worth $258M as of Q2 2026.
  • Lindsell Train sold 102,699 Thermo Fisher Scientific shares in Q2 2026, an estimated $49.3M.
  • Thermo Fisher Scientific made up 9.81% of Lindsell Train's portfolio in Q2 2026, its #4 holding.
  • Lindsell Train first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Lindsell Train's Thermo Fisher Scientific position peaked at $400M in Q4 2025.
  • 429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lindsell Train's 13F filing for Q2 2026, filed 15 Jul 2026.